The New Victoria Hospital is an ambulatory care hospital situated at Langside/Battlefield in the south-east of Glasgow. It is managed by NHS Greater Glasgow and Clyde.

During the past decade, Victoria Infirmary conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Victoria Infirmary" #1 sponsor was "Glasgow Caledonian University" with 2 trials, followed by "NHS Greater Glasgow and Clyde" with 2 trials sponsored, "Cardiff University" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "Faron Pharmaceuticals Ltd" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Victoria Infirmary" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "Borstkanker Onderzoek Groep" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator and "Chief Scientist Office of the Scottish Government" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Victoria Infirmary" are "Breast Cancer" (2 trials), "Pelvic Organ Prolapse" (2 trials), "Acute Lung Injury" (1 trials), "Acute Myeloid Leukaemia" (1 trials) and "Acute Respiratory Distress Syndrome" (1 trials). Many other conditions were trialed in "Victoria Infirmary" in a lesser frequency.

Most popular intervention types in "Victoria Infirmary" are "Drug" (7 trials), "Behavioral" (1 trials), "Dietary Supplement" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arm A Mylotarg plus DA Versus CPX-351" (1 trials), "Arm B Vosaroxin and Decitabine" (1 trials), "Arm C DA V FLAG-Ida V DAC" (1 trials), "Arm D Small molecule or Not" (1 trials) and "Arm E CPX-351 (200 V 300)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Victoria Infirmary" are 8 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Victoria Infirmary". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Victoria Infirmary, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Victoria Infirmary, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".